Jennifer Ann Jarrett's Insider Trades & SAST Disclosures
Jennifer Ann Jarrett's most recent trade in Syndax Pharmaceuticals Inc was a trade of 25,000 Common Stock done . Disclosure was reported to the exchange on Feb. 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jennifer Ann Jarrett.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc | Jennifer Ann Jarrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 25,000 | 90,000 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 50,000 | 213,369 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.08 per share. | 15 Dec 2024 | 27,501 | 163,369 (0%) | 0% | 16.1 | 442,216 | Common Stock |
| Zura Bio Ltd - Ordinary Sh... | Jennifer Ann Jarrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 117,000 | 117,000 | - | - | Share Option (Right to Buy) | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.95 per share. | 15 Sep 2024 | 12,670 | 190,394 (0%) | 0% | 18.0 | 227,427 | Common Stock |
| Sagimet Biosciences Inc - ... | Jennifer Ann Jarrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 113,895 | 113,895 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.97 per share. | 15 Jun 2024 | 12,670 | 203,064 (0%) | 0% | 17.0 | 215,010 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.55 per share. | 27 Mar 2024 | 11,551 | 215,253 (0%) | 0% | 17.5 | 202,720 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.84 per share. | 18 Mar 2024 | 12,153 | 228,100 (0%) | 0% | 17.8 | 216,810 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.62 per share. | 18 Mar 2024 | 1,296 | 226,804 (0%) | 0% | 18.6 | 24,132 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett Ann | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.11 per share. | 26 Feb 2024 | 34,070 | 240,253 (0%) | 0% | 20.1 | 685,148 | Common Stock |
| Arcus Biosciences Inc | Ann Jennifer Jarrett | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.07 per share. | 26 Feb 2024 | 24,555 | 274,323 (0%) | 0% | 20.1 | 492,819 | Common Stock |
| Syndax Pharmaceuticals Inc | Ann Jarrett Jennifer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 17,000 | 65,000 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 162,400 | 162,400 | - | - | Stock Option (right to buy) | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 40,000 | 298,878 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Jarrett Ann Jennifer | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.76 per share. | 22 Dec 2023 | 21,521 | 258,878 (0%) | 0% | 17.8 | 382,213 | Common Stock |
| Arcus Biosciences Inc | Ann Jarrett Jennifer | Director, Chief Operating Officer | Sale or transfer of securities back to the company at price $ 18.09 per share. | 18 Dec 2023 | 11,492 | 280,399 (0%) | 0% | 18.1 | 207,890 | Common Stock |
| Arcus Biosciences Inc | Ann Jennifer Jarrett | Director, Chief Operating Officer | Sale or transfer of securities back to the company at price $ 17.74 per share. | 18 Dec 2023 | 11,250 | 291,891 (0%) | 0% | 17.7 | 199,575 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 19.99 per share. | 22 Sep 2023 | 21,369 | 302,691 (0%) | 0% | 20.0 | 427,166 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale or transfer of securities back to the company at price $ 20.40 per share. | 18 Sep 2023 | 12,506 | 324,060 (0%) | 0% | 20.4 | 255,122 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.25 per share. | 28 Jul 2023 | 45,000 | 336,566 (0%) | 0% | 20.3 | 911,250 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 19.12 per share. | 22 Jun 2023 | 12,437 | 381,566 (0%) | 0% | 19.1 | 237,795 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 19.35 per share. | 16 Jun 2023 | 12,563 | 394,003 (0%) | 0% | 19.3 | 243,094 | Common Stock |
| Zura Bio Ltd - Ordinary Sh... | Jennifer Ann Jarrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 7,652 | 7,652 | - | - | Employee Share Option (Right to Buy) | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.81 per share. | 16 Mar 2023 | 8,729 | 406,217 (0%) | 0% | 16.8 | 146,734 | Common Stock |
| Syndax Pharmaceuticals Inc | Jennifer Ann Jarrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 16,000 | 48,000 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 23.52 per share. | 26 Jan 2023 | 1,600 | 414,946 (0%) | 0% | 23.5 | 37,632 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 23.56 per share. | 26 Jan 2023 | 300 | 416,546 (0%) | 0% | 23.6 | 7,068 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2023 | 185,900 | 185,900 | - | - | Stock Option (right to buy) | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2023 | 45,800 | 416,846 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.66 per share. | 16 Dec 2022 | 13,879 | 150,212 (0%) | 0% | 30.7 | 425,530 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.23 per share. | 16 Dec 2022 | 2,603 | 147,609 (0%) | 0% | 31.2 | 81,292 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 26.28 per share. | 16 Sep 2022 | 12,677 | 130,942 (0%) | 0% | 26.3 | 333,152 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.72 per share. | 16 Jun 2022 | 6,081 | 125,233 (0%) | 0% | 20.7 | 125,998 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 22.29 per share. | 16 Jun 2022 | 4,663 | 118,619 (0%) | 0% | 22.3 | 103,938 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 21.71 per share. | 16 Jun 2022 | 1,951 | 123,282 (0%) | 0% | 21.7 | 42,356 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.62 per share. | 16 Mar 2022 | 9,617 | 105,978 (0%) | 0% | 31.6 | 304,090 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 31,250 | 121,845 (0%) | 0% | 0 | Common Stock | |
| Syndax Pharmaceuticals Inc | Jennifer Ann Jarrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 16,000 | 32,000 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges